Floatz logo

Melatonin

Sleep Disorder

Duke UniversitySmall moleculePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Sleep Disorder cohort.

Asset / SponsorPhaseRating
Trazodone
Johns Hopkins University
Phase 4BB
Rasagiline
Technische Universität Dresden
Phase 4BB
Armodafinil
Cephalon
Phase 4BB
Olanzapine
Central Institute of Psychiatry, Ranchi, India
Phase 4BB
Fremanezumab
Beth Israel Deaconess Medical Center
Phase 4BB

View all 34 →

Same molecule, other indications

Melatonin is also rated in:

traumatic brain injuryActive
BBB
Indicative · Phase 4
74 / 100
View asset →
bipolar disorderActive
BBB
Indicative · Phase 4
72 / 100
View asset →
circadian rhythm sleep disorderActive
BB
Indicative · Phase 4
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →